• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Endocrine therapy in the management of low-grade serous ovarian/peritoneal carcinoma: Mounting evidence for therelative efficacy of tamoxifen and aromatase inhibitors.

作者信息

Gershenson David M, Cobb Lauren P, Sun Charlotte C

机构信息

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

出版信息

Gynecol Oncol. 2020 Dec;159(3):601-603. doi: 10.1016/j.ygyno.2020.09.049. Epub 2020 Oct 2.

DOI:10.1016/j.ygyno.2020.09.049
PMID:33019983
Abstract
摘要

相似文献

1
Endocrine therapy in the management of low-grade serous ovarian/peritoneal carcinoma: Mounting evidence for therelative efficacy of tamoxifen and aromatase inhibitors.低度浆液性卵巢/腹膜癌治疗中的内分泌治疗：他莫昔芬和芳香化酶抑制剂相对疗效的证据不断增加。
Gynecol Oncol. 2020 Dec;159(3):601-603. doi: 10.1016/j.ygyno.2020.09.049. Epub 2020 Oct 2.
2
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.PARAGON 研究：阿那曲唑治疗雌激素受体阳性复发性/转移性低级别卵巢癌和浆液性交界性卵巢肿瘤患者的 II 期研究。
Gynecol Oncol. 2019 Sep;154(3):531-538. doi: 10.1016/j.ygyno.2019.06.011. Epub 2019 Jun 18.
3
Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum.复发性低级别浆液性卵巢或腹膜癌的激素治疗。
Gynecol Oncol. 2012 Jun;125(3):661-6. doi: 10.1016/j.ygyno.2012.02.037. Epub 2012 Mar 6.
4
A randomized comparison of triptorelin and tamoxifen as treatment of progressive ovarian cancer.曲普瑞林与他莫昔芬治疗进展期卵巢癌的随机对照研究
Anticancer Res. 1995 Nov-Dec;15(6B):2639-42.
5
Endocrine treatment of high grade serous ovarian carcinoma; quantification of efficacy and identification of response predictors.高级别浆液性卵巢癌的内分泌治疗；疗效的量化和反应预测因子的鉴定。
Gynecol Oncol. 2019 Feb;152(2):278-285. doi: 10.1016/j.ygyno.2018.11.030. Epub 2018 Nov 28.
6
Clinical benefit and risk of death with endocrine therapy in ovarian cancer: A comprehensive review and meta-analysis.临床获益与内分泌治疗卵巢癌死亡风险：全面综述和荟萃分析。
Gynecol Oncol. 2017 Sep;146(3):504-513. doi: 10.1016/j.ygyno.2017.06.036. Epub 2017 Jul 10.
7
Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.卵巢或腹膜低级别浆液性癌的新辅助化疗。
Gynecol Oncol. 2008 Mar;108(3):510-4. doi: 10.1016/j.ygyno.2007.11.013. Epub 2007 Dec 26.
8
Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas.雌激素和孕激素受体免疫染色在鉴别腹膜间皮瘤和浆液性癌中的价值。
Hum Pathol. 2005 Nov;36(11):1163-7. doi: 10.1016/j.humpath.2005.08.008. Epub 2005 Sep 22.
9
Estrogen and progesterone receptors in breast cancer.乳腺癌中的雌激素和孕激素受体
Clin Adv Hematol Oncol. 2011 May;9(5):385-6.
10
Current advances in endocrine therapy options for premenopausal women with hormone receptor positive breast cancer.激素受体阳性绝经前乳腺癌女性内分泌治疗选择的当前进展
Gynecol Oncol. 2017 Oct;147(1):153-157. doi: 10.1016/j.ygyno.2017.06.023. Epub 2017 Jun 26.

引用本文的文献

1
Treatment of ovarian cancer: From the past to the new era (Review).卵巢癌的治疗：从过去到新时代（综述）
Oncol Lett. 2025 Jun 3;30(2):384. doi: 10.3892/ol.2025.15130. eCollection 2025 Aug.
2
Endocrine Maintenance Therapy in High-Grade Serous Ovarian Cancer: A Retrospective Off-Label Real-World Cohort Study.高级别浆液性卵巢癌的内分泌维持治疗：一项回顾性非标签真实世界队列研究
Cancers (Basel). 2025 Apr 12;17(8):1301. doi: 10.3390/cancers17081301.
3
The Megacomplex protects ER-alpha from degradation by Fulvestrant in epithelial ovarian cancer.
在上皮性卵巢癌中，超大复合物可保护雌激素受体α不被氟维司群降解。
Cancer Lett. 2025 Jan 1;608:217129. doi: 10.1016/j.canlet.2024.217129. Epub 2024 Jul 22.
4
Steroid metabolism and hormonal dynamics in normal and malignant ovaries.正常及恶性卵巢中的类固醇代谢与激素动态变化
Essays Biochem. 2024 Dec 4;68(4):491-507. doi: 10.1042/EBC20240028.
5
Ocular side effects of anticancer agents used in the treatment of gynecologic cancers.妇科恶性肿瘤治疗药物的眼部不良反应。
Gynecol Oncol. 2024 Sep;188:147-157. doi: 10.1016/j.ygyno.2024.06.003. Epub 2024 Jul 4.
6
Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival.当代II-IV期低级别浆液性卵巢/腹膜癌（LGSOC）女性的初始治疗：复发和无病生存的决定因素
Gynecol Oncol. 2022 Nov;167(2):139-145. doi: 10.1016/j.ygyno.2022.09.005. Epub 2022 Sep 20.